Loading organizations...
NewHealth Ventures operates as a pioneering venture capital fund, primarily focused on the Latin American market. The firm invests in disruptive, clinically validated medical technologies globally to address critical healthcare needs. Its portfolio includes AI-powered diagnostics for cancer, digital platforms for genomic workflows, and AI-enabled virtual care for chronic pain.
NewHealth Ventures originated from the insight that Latin America offers significant opportunity for impactful health innovation investment. Established as the first LATAM VC fund dedicated to globally sourced, clinically validated medical technologies, it recognizes the region's potential for adopting these advancements.
The technologies NewHealth Ventures supports ultimately serve healthcare providers and patients by enhancing diagnostic accuracy, improving access to genetic insights, and transforming chronic pain treatment. The firm’s vision centers on transforming healthcare outcomes through technologies that deliver tangible clinical benefits and foster a healthier future, emphasizing the LATAM region.
NewHealth Ventures has 1 tracked investment across 1 company. The latest tracked deal is $11.0M Series A in Lin Health in December 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 9, 2025 | Lin Health | $11.0M Series A | DAN Goldsmith | Mayo Clinic, Osage Venture Partners, Saban Ventures, Shoni TOP Ventures, Viola Ventures |
